SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-055199
Filing Date
2023-07-06
Accepted
2023-07-06 17:00:10
Documents
13
Period of Report
2023-06-29
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea181441-8k_bluewater.htm   iXBRL 8-K 26429
2 LETTER FROM MAYER HOFFMAN MCCANN P.C., DATED JULY 6, 2023. ea181441ex16-1_bluewater.htm EX-16.1 2866
  Complete submission text file 0001213900-23-055199.txt   205543

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bwv-20230629.xsd EX-101.SCH 2944
4 XBRL LABEL FILE bwv-20230629_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bwv-20230629_pre.xml EX-101.PRE 22350
7 EXTRACTED XBRL INSTANCE DOCUMENT ea181441-8k_bluewater_htm.xml XML 3720
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Blue Water Biotech, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 231074249
SIC: 2834 Pharmaceutical Preparations